These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15203435)

  • 1. Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol-A in mice.
    Mizuo K; Narita M; Yoshida T; Narita M; Suzuki T
    Addict Biol; 2004 Mar; 9(1):19-25. PubMed ID: 15203435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state.
    Suzuki T; Mizuo K; Nakazawa H; Funae Y; Fushiki S; Fukushima S; Shirai T; Narita M
    Neuroscience; 2003; 117(3):639-44. PubMed ID: 12617968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exposure to bisphenol-A affects the rewarding system in mice].
    Suzuki T; Mizuo K; Miyagawa K; Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):125-8. PubMed ID: 16045194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice.
    Mizuo K; Narita M; Miyagawa K; Narita M; Okuno E; Suzuki T
    Neurosci Lett; 2004 Feb; 356(2):95-8. PubMed ID: 14746872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol-A in mice: evidence for the importance of exposure period.
    Narita M; Miyagawa K; Mizuo K; Yoshida T; Suzuki T
    Addict Biol; 2007 Jun; 12(2):167-72. PubMed ID: 17508988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect.
    Narita M; Miyagawa K; Mizuo K; Yoshida T; Suzuki T
    Neurosci Lett; 2006 Jul; 402(3):249-52. PubMed ID: 16678967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes in dopaminergic neurotransmission induced by a low concentration of bisphenol-A in neurones and astrocytes.
    Miyatake M; Miyagawa K; Mizuo K; Narita M; Suzuki T
    J Neuroendocrinol; 2006 Jun; 18(6):434-44. PubMed ID: 16684133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal and postnatal exposure to bisphenol a induces anxiolytic behaviors and cognitive deficits in mice.
    Tian YH; Baek JH; Lee SY; Jang CG
    Synapse; 2010 Jun; 64(6):432-9. PubMed ID: 20169576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
    Chagas-Martinich L; Carey RJ; Carrera MP
    Pharmacol Biochem Behav; 2007 Mar; 86(3):441-8. PubMed ID: 17291574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
    Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
    Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Prenatal Exposure to a Low-Dose of Bisphenol A on Sex Differences in Emotional Behavior and Central Alpha
    Ponzi D; Gioiosa L; Parmigiani S; Palanza P
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.
    Pritchard LM; Logue AD; Hayes S; Welge JA; Xu M; Zhang J; Berger SP; Richtand NM
    Neuropsychopharmacology; 2003 Jan; 28(1):100-7. PubMed ID: 12496945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ropinirole regulates emotionality and neuronal activity markers in the limbic forebrain.
    Mavrikaki M; Schintu N; Nomikos GG; Panagis G; Svenningsson P
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):1981-93. PubMed ID: 24852388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of newborn male and female rats to environmental estrogens: delayed and sustained hyperprolactinemia and alterations in estrogen receptor expression.
    Khurana S; Ranmal S; Ben-Jonathan N
    Endocrinology; 2000 Dec; 141(12):4512-7. PubMed ID: 11108262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of dopamine-induced signaling responses in the forebrain of mice lacking dopamine D3 receptor.
    Mizuo K; Narita M; Miyatake M; Suzuki T
    Neurosci Lett; 2004 Mar; 358(1):13-6. PubMed ID: 15016423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of dopamine D(3) receptors induces c-fos expression in primary cultures of rat striatal neurons.
    Morris BJ; Newman-Tancredi A; Audinot V; Simpson CS; Millan MJ
    J Neurosci Res; 2000 Mar; 59(6):740-9. PubMed ID: 10700011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1999 Jan; 20(1):60-80. PubMed ID: 9885786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.